mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.062 |
0.3 |